You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Cervical Cancer Screening

Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria:

  • Women age 21-64 who had cervical cytology performed every 3 years.
  • Women age 30-64 who had cervical cytology/human papillomavirus (HPV) co-testing performed every 5 years.
Date Reviewed: November 17, 2017

Measure Info

MIPS 309NQF 0032CMS 309NQF EndorsedCQMC Core Measure
Measure Type: 
Measure Steward: 
National Committee for Quality Assurance
Clinical Topic Area: 
Cancer Screening
Prevention and Wellness
Women's Preventive Services

Care Setting: 
Clinician Office/Clinic
Data Source: 
Administrative Claims
Electronic Health Records
Paper Medical Records

ACP supports QPP measure 309: "Cervical Cancer Screening" because the current evidence supports screening in women 21-64 years of age and this measure is based on the most recent United States Preventive Services Task Force recommendations on cervical cancer screening.